4.66
0.17 (3.67%)
| Penutupan Terdahulu | 4.50 |
| Buka | 4.54 |
| Jumlah Dagangan | 2,005,487 |
| Purata Dagangan (3B) | 2,513,733 |
| Modal Pasaran | 584,884,288 |
| Harga / Jualan (P/S) | 11.46 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2026 |
| Margin Keuntungan | -100.02% |
| Margin Operasi (TTM) | -222.08% |
| EPS Cair (TTM) | -0.580 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -27.70% |
| Nisbah Semasa (MRQ) | 4.87 |
| Aliran Tunai Operasi (OCF TTM) | -48.77 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -20.21 M |
| Pulangan Atas Aset (ROA TTM) | -22.21% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | Aquestive Therapeutics, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | 1.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 4.0 |
| Purata | 0.72 |
|
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 5.62% |
| % Dimiliki oleh Institusi | 48.90% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Bratton Capital Management, L.P. | 30 Jun 2026 | 9,810,958 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BARBER DANIEL | - | 4.29 | -25,000 | -107,250 |
| Jumlah Keseluruhan Kuantiti Bersih | -25,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -107,250 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 4.29 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| BARBER DANIEL | Pegawai | 17 Aug 2026 | Jual (-) | 25,000 | 4.29 | 107,250 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |